Characterization of HIV-1 drug resistance among patients with failure of second-line combined antiretroviral therapy in central Ethiopia.

Tafese Beyene TufaAndre FuchsHans Martin OrthNadine LübkeElena KnopsEva HegerGodana JarsoZewdu HurissaYannik EggersDieter HäussingerTom LueddeBjörn-Erik Ole JensenRolf KaiserTorsten Feldt

Published in: HIV medicine (2021)

We found a high prevalence of resistance mutations, also against PIs (40%), as the national standard second-line cART components. Resistance testing before switching to second- or third-line cART is warranted.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
hiv aids
hiv infected patients
quality improvement
hiv testing
hepatitis c virus
men who have sex with men